Clinical Trials Browser

Phase 1/2 × Advanced Solid Tumor × lenvatinib × Clear all

NCT06682780 2025-09-25

A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT06081907 2024-05-30

Promise

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor